GlassScriptPhysician profile
Joseph Loiodice
NPI 1548317761
$718.75
in general payments reported to CMS, 2019-2025
16 companies · $566 in 2025
The $566 reported for 2025 was more than what 76% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $18.79 · 2023: $23.00 · 2024: $111 · 2025: $566.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $699.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Renalytix Ai, INC. | $137.16 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Echosens North America, INC. | $94.33 | 2025 | Fibroscan |
| Glaxosmithkline, LLC. | $89.42 | 2025 | Nucala |
| Novo Nordisk INC | $66.75 | 2023-2024 | Rybelsus, Ozempic |
| Lilly USA, LLC | $65.20 | 2022-2025 | Mounjaro, Zepbound |
| Shield Therapeutics INC | $44.50 | 2025 | |
| Tactile Systems Technology INC | $30.15 | 2025 | Flexitouch Plus, Nimbl |
| Daiichi Sankyo INC. | $24.32 | 2024 | Injectafer |
| Regeneron Healthcare Solutions, INC. | $24.06 | 2024 | Dupixent |
| Astellas Pharma US INC | $24.04 | 2025 | Veozah |
| Exact Sciences Corporation | $21.58 | 2025 | The Cologuard Plus Collection Kit |
| Genzyme Corporation | $20.66 | 2025 | |
| Amgen INC. | $20.23 | 2025 | Otezla, Repatha |
| Axsome Therapeutics, INC. | $20.00 | 2025 | Symbravo |
| Astrazeneca Pharmaceuticals LP | $18.72 | 2024 | Airsupra |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $17.63 | 2025 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Loiodice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.